Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-12-17
2010-10-19
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S236000, C544S238000, C544S239000, C544S240000, C544S224000, C544S234000
Reexamination Certificate
active
07816357
ABSTRACT:
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I.including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R1, R2, R3, R4, R5, m and n are described herein.
REFERENCES:
patent: 4581449 (1986-04-01), Parravicini et al.
patent: 6610694 (2003-08-01), Kawano et al.
patent: 2004/0063580 (2004-04-01), Kuragano et al.
patent: 2005/0171110 (2005-08-01), Yu et al.
patent: 1 120 418 (2001-08-01), None
patent: 1 568 398 (1980-05-01), None
patent: 61106576 (1986-05-01), None
patent: WO 98/04559 (1998-02-01), None
patent: WO 00/20417 (2000-04-01), None
patent: WO 01/58869 (2001-08-01), None
patent: WO 02/38562 (2002-05-01), None
patent: WO 03/007887 (2003-01-01), None
patent: WO 2004/074259 (2004-09-01), None
patent: WO2005/061509 (2005-07-01), None
Lange, et al., Acta Poloniae Pharmaceutica (1996), 53(6), 431-436. [Two Page Abstract].
Deeb, A. et al, “Studies on Polyazaindenes Synthesis of Several New Condensed Pyridazine Derivatives”, Collect. Czech. Chem. Commun., vol. 55, pp. 2795-2799 (1990).
U.S. Appl. No. 11/015,876, filed Dec. 17, 2004, Ewing et al.
U.S. Appl. No. 11/016,135, filed Dec. 17, 2004, Yu et al.
Ellsworth Bruce A.
Ewing William R.
Gerritz Samuel
Mikkilineni Amarendra B.
Murugesan Natesan
Bristol--Myers Squibb Company
Jaisle Cecilia M
Wilson James O
Winslow Anastasia P.
LandOfFree
Azabicyclic heterocycles as cannabinoid receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azabicyclic heterocycles as cannabinoid receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabicyclic heterocycles as cannabinoid receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4224127